5 mmHg and < 21 mmHg with or with- out antiglaucoma medications and with- out additional glaucoma surgery needed (Table 1). The mean postoperative follow-up was 30.1 months. Surgical success rate was 86.9% at 1 year. Similar success rates were found for those patients under (n = 10) and above (n = 46) 30 years of age (84% versus 87%, at 1 year after surgery). The IOP was reduced from a preoperative mean of 37.4 Æ11.6 mmHg to a postoperative mean of 11.5 Æ3.9 mmHg (1 year). At final follow-up, the mean IOP was 12.4 Æ5.2 mmHg. At last follow-up, 50 (82%) patients had a BCVA that was either unchanged, improved or within 1 line of preoperative levels. There were no intraoperative complications in this series. There were also no cases of endophthalmitis, loss of light percep- tion or tube-related complications. Multivariate regression analyses showed that none of the preoperative characteristics, including type of uvei- tis, uveitis activity before and after surgery and ethnicity, were associated with a higher risk of surgical failure. We found a high percentage of success for the Baerveldt GDI in uveitic glaucoma (86.9% at 1 year), which is comparable to the 91.7% success rate in the only other report published about the very same subject (Ceballos et al. 2002). Our outcomes compared favourably with previous studies using other GDI in uveitic glaucoma, reporting success rates of 79% at 1 year using Molteno GDIs and 77% using Ahmed GDIs (Hill et al. 1993; Papadaki et al. 2007). Chawla et al. (2013) demonstrated good long-term survival rates of 5FU-enhanced trabeculectomy in patients with uveitic glaucoma, compa- rable with results for primary open- angle glaucoma. However, they reported that patients under 30 years of age were at a higher risk for failure and 50% in this age group went on to require GDI surgery. For the Baerveldt GDI in this study, we found similar success rates for those patients under and above 30 years of age. When we look at the result of the previous studies and combine these results with our find- ings, we could advise a primary Baerveldt GDI for uveitic glaucoma in patients under 30 years of age. In older patients, a trabeculectomy would be a reasonable first surgical option in the management of uncontrolled uvei- tic glaucoma. Subsequently, a Baer- veldt GDI can still be used in the future if needed. References Ceballos EM, Parrish RK II & Schiffman JC (2002): Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 209: 2256–2260. Chawla A, Mercieca K, Fenerty C et al. (2013): Outcomes and complications of tra- beculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22: 663–666. Hill R, Nguygen QH, Baerveldt G et al. (1993): Trabeculectomy and Molteno implantation for glaucoma associated with uveits. Ophthalmology 100: 903–908. Papadaki TG, Zacharopoulos IP, Pascuala LR et al. (2007): Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 144: 62–69. Rothova A, Suttorp-van Schulten MSA, Tref- fers WF et al. (1996): Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80: 332–336. Correspondence: Roselie M. Diederen Department of Ophthalmology Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands Tel: 0031205669111 Fax: 0205669078 Email: rmhdiederen@gmail.com Potential link between sporadic cerebral amyloid angiopathy and vision loss: a case report Rupali Vohra, 1,2 Tina D. Hjortshøj, 3 Mette M. Nordling, 4 Torben L. Sørensen, 1,5 Peter K. Jensen 1 and Miriam Kolko 1,2,6 1 Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark; 2 Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; 3 Department of Clinical Genetics, Kennedy Center, University Hospital of Copenhagen, Copenhagen, Denmark; 4 Department of Radiology, Zealand University Hospital, Roskilde, Denmark; 5 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 6 Department of Ophthalmology, Rigshospitalet, Glostrup, Denmark doi: 10.1111/aos.13681 Editor, A myloids have been linked to the development of various diseases. Cerebral amyloid angiopathy (CAA) is one of the conditions caused by amy- loid deposits in the small and mid-sized vessels (Yamada 2015). Cerebral amy- loid angiopathy mainly affects the brain, and only few cases describing vascular changes in the retina in patients with CAA have been reported and are predominantly hereditary cases Table 1. Intraocular pressure (IOP) and visual acuity. Preoperative (n = 61) 6 months Postoperative (n = 61) 12 months Postoperative (n = 48) 24 months Postoperative (n = 39) Last Follow-up (n = 61) Visual acuity (LogMAR) (mean Æ SD) 0.45 Æ 0.55 0.44 Æ 0.50 0.38 Æ 0.46 0.46 Æ 0.50 0.41 Æ 0.50 IOP (mmHg) (mean Æ SD) 37.4 Æ 11.6 11.6 Æ 5.1 11.5 Æ 3.9 12.4 Æ 4.5 12.4 Æ 5.2 Antiglaucoma medications (mean Æ SD) 12.2 Æ 1.5 0.7 Æ 1.0 0.6 Æ 0.9 0.8 Æ 1.1 0.6 Æ 1.1 Patients without medication (%) 0 50.8 67.8 36.1 67.2 IOP = intraocular pressure; SD = standard deviation. Acta Ophthalmologica 2018 e753